BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2024-12-13
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: €0.56 M
• Last year FTD volume: €0.56 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Repligen RGEN	€1.6 M	€38.97 M	🇺🇸 USA
Sarepta Therapeutics SRPT	€9.53 M	€42.18 M	🇺🇸 USA
NanoViricides NNVC	€1.12 M	€3.63 M	🇺🇸 USA
Novavax NVAX	€27.35 M	€0.15 B	🇺🇸 USA
Gilead Sciences GILD	€47.11 M	€0.21 B	🇺🇸 USA
Celldex Therapeutics CLDX	€0.91 M	€6.08 M	🇺🇸 USA
GlaxoSmithKline GSK	€57.9 M	€0.10 B	🇬🇧 UK
Emergent BioSolutions EBS	€1.42 M	€5.72 M	🇺🇸 USA
Cel-Sci CVM	€0.53 M	€2.67 M	🇺🇸 USA